Aliases: DEE90, FGF-13, FGF2, FHF-2, FHF2, LINC00889
Chromosome No: X
Chromosome Band: Xq26.3
Genetic Category: Syndromic
ASD Reports: 2
Recent Reports: 0
Annotated variants: 6
Associated CNVs: 12
Evidence score: 2
Associated Disorders: |
|
Relevance to Autism
Fry et al., 2021 demonstrated that missense variants in the N-terminal domain of the A isoform of the FGF13 gene caused an X-linked developmental and epileptic encephalopathy (developmental and epileptic encephalopathy-90; OMIM 301058); all seven affected individuals in this report (two sibling pairs and three unrelated males) presented with intractable focal seizures and severe-profound developmental delay/intellectual disability, and four individuals were diagnosed with autism spectrum disorder. Furthermore, functional characterization of FGF13 missense variants in this report revealed that mutation proteins lost the ability to induce rapid-onset, long-term blockade of wild-type Nav1.6 (SCN8A) channels while retaining pro-excitatory properties, consistent with a gain-of-function effect.
Molecular Function
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked cognitive disability mapping to this region.